News about CIBERER

Allopurinol is designated as the first orphan drug for the treatment of Marfan syndrome

IDIBAPS-Hospital Clínic, the University of Barcelona (UB) and CIBERER are promoting this new advance to fight against a genetic and minority disease1

Clínic Barcelona

Research June 26 2024

A key mechanism is discovered in Idiopathic Inflammatory Myopathies

Researchers from the Clínic-IDIBAPS have taken part in a study that provides new information on the mechanisms involved in idiopathic inflammatory my1

Clínic Barcelona

Research May 3 2024

A study by BCNatal and UPF opens the door to designing therapies to improve lung development in growth-restricted fetuses

The study, carried out by the BCNatal Fetal Medicine Research Center (Hospital Clínic Barcelona and Hospital Sant Joan de Déu) and the UPF BCN MedTec1

Clínic Barcelona

Research December 7 2021

Mediterranean diet or mindfulness during pregnancy reduces by one third the risk of a low birth weight baby

Mediterranean diet or mindfulness-based stress reduction interventions during pregnancy reduce the prevalence of low birth weight by 29-36% as well a1

News about CIBERER

Allopurinol is designated as the first orphan drug for the treatment of Marfan syndrome

A key mechanism is discovered in Idiopathic Inflammatory Myopathies

A study by BCNatal and UPF opens the door to designing therapies to improve lung development in growth-restricted fetuses

Mediterranean diet or mindfulness during pregnancy reduces by one third the risk of a low birth weight baby

Subscribe to the Newsletter of Clínic